Recombinant Human Neuroligin 3/NLGN3 Protein, CF Summary
Ala39-Ser709 (Ser92Tyr), with a C-terminal 6-His tag
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
When Recombinant Human Neuroligin 3/NLGN3 (Catalog # 9069-NL) is immobilized at 2 µg/mL, Biotinylated Recombinant Human Neurexin 1 beta Fc Chimera binds with a typical ED50 of 150-900 ng/mL.
Background: Neuroligin 3/NLGN3
Neuroligin 3 (NLGN3) is one of several type I transmembrane Neuroligin proteins that play an important role in synaptic development (1, 2). Mature human Neuroligin 3 is an approximately 120 kDa molecule that consists of a 672 amino acid (aa) extracellular domain (ECD) with a catalytically inactive cholinesterase-like domain, a 21 aa transmembrane segment, and a 118 aa cytoplasmic tail (3). Alternative splicing generates additional isoforms with 20 aa or 40 aa deletions in the ECD (3-5). Within the ECD, human Neuroligin 3 shares 99% aa sequence identity with comparable regions of mouse and rat Neuroligin 3. It is expressed during development on astrocytes and Schwann cells (6) as well as on neurons where it localizes to synaptic membranes and post-synaptic densities of both glutamatergic and GABAergic synapses (7). It associates in cis with Neuroligin 1 and Neuroligin 2 and trans-synaptically with Neurexin-1 beta, -2 beta, and -3 beta that lack the splice site 4 insertion (3, 7). A soluble form of the Neuroligin 3 ECD can be released by neurons and promotes glioma cell proliferation (8). Mutations in Neuroligin 3 enhance neuronal dendritic branching, alter both excitatory and inhibitory synaptic activity (9-12), and are associated with the development of autism spectrum disorder (13, 14).
- Bemben, M.A. et al. (2015) Trends Neurosci. 38:496.
- Mackowiak, M. et al. (2014) Pharmacol. Rep. 66:830.
- Ichtchenko, K. et al. (1996) J. Biol. Chem. 271:2676.
- Philibert, R.A. et al. (2000) Gene 246:303.
- Talebizadeh, Z. et al. (2006) J. Med. Genet. 43:e21.
- Gilbert, M. et al. (2001) Glia 34:151.
- Budreck, E.C. and P. Scheiffele (2007) Eur. J. Neurosci. 26:1738.
- Venkatesh, H.S. et al. (2015) Cell 161:803.
- Etherton, M. et al. (2011) Proc. Natl. Acad. Sci. USA 108:13764.
- Foldy, C. et al. (2013) Neuron 78:498.
- Tabuchi, K. et al. (2007) Science 318:71.
- Gutierrez, R.C. et al. (2009) Neuroscience 162:208.
- Jamain, S. et al. (2003) Nat. Genet. 34:27.
- Rothwell, P.E. et al. (2014) Cell 158:198.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Protein Purification Kits
Reviews for Recombinant Human Neuroligin 3/NLGN3 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Neuroligin 3/NLGN3 Protein, CF and earn rewards!
Have you used Recombinant Human Neuroligin 3/NLGN3 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image